Fusion Antibodies Balance Sheet Health
Financial Health criteria checks 6/6
Fusion Antibodies has a total shareholder equity of £1.5M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £2.1M and £604.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£487.00k |
| Equity | UK£1.45m |
| Total liabilities | UK£604.00k |
| Total assets | UK£2.06m |
Recent financial health updates
Here's Why We're Not At All Concerned With Fusion Antibodies' (LON:FAB) Cash Burn Situation
Aug 31
Here's Why We're Not Too Worried About Fusion Antibodies' (LON:FAB) Cash Burn Situation
Jan 25We Think Fusion Antibodies (LON:FAB) Can Easily Afford To Drive Business Growth
May 09Companies Like Fusion Antibodies (LON:FAB) Can Afford To Invest In Growth
Jan 04Recent updates
Here's Why We're Not At All Concerned With Fusion Antibodies' (LON:FAB) Cash Burn Situation
Aug 31Here's Why We're Not Too Worried About Fusion Antibodies' (LON:FAB) Cash Burn Situation
Jan 25We Think Fusion Antibodies (LON:FAB) Can Easily Afford To Drive Business Growth
May 09Investors Who Bought Fusion Antibodies (LON:FAB) Shares A Year Ago Are Now Up 146%
Mar 17Companies Like Fusion Antibodies (LON:FAB) Can Afford To Invest In Growth
Jan 04Financial Position Analysis
Short Term Liabilities: FAB's short term assets (£1.8M) exceed its short term liabilities (£554.0K).
Long Term Liabilities: FAB's short term assets (£1.8M) exceed its long term liabilities (£50.0K).
Debt to Equity History and Analysis
Debt Level: FAB is debt free.
Reducing Debt: FAB has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: FAB has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: FAB is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.